Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alliinase is a major pyridoxal phosphate (PLP)-dependent enzyme found in garlic (Allium sativum L.) bulbs, where it serves as a key component in the biosynthesis of allicin, the organosulfur compound responsible for garlic's characteristic aroma and many of its medicinal properties[1]. Unlike a membrane receptor or channel, alliinase is a soluble, homodimeric glycoprotein with N-linked oligosaccharides. When garlic cloves are crushed or injured, the enzyme is released from cell vacuoles and converts the precursor alliin into allicin, which is produced only transiently and breaks down rapidly into other sulfur-containing compounds (e.g., diallyl disulfide, ajoenes)[2]. Allicin, along with its breakdown products, is responsible for much of garlic's antimicrobial, antioxidant, and pharmacologic effects, and these compounds are under investigation for their potential therapeutic roles in cardiovascular disease, infection, inflammation, and metabolic disorders[3]. Alliinase is not itself a therapeutic target in the classic sense, but rather a catalyst for the formation of bioactive compounds such as allicin, which have biologic activity. The enzyme's structure (PDB: 2HOX) has been crystallographically resolved, revealing details of its active site, cofactor (PLP) binding, and reaction intermediates[1].
Catalyzes the conversion of alliin ((+S)-allyl-L-cysteine sulfoxide) to allicin (diallyl thiosulfinate), pyruvate, and ammonia; cleavage of S-allyl-L-cysteine sulfoxide via an alpha, beta-lyase (elimination) reaction[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alliinase (alliin lyase; EC 4.4.1.4) from Allium sativum L. (garlic) (Alliinase).